GlassScriptPhysician profile
Wendy Mc Bui
NPI 1780141895
$6,550.88
in general payments reported to CMS, 2019-2025
44 companies · $2,304 in 2025
The $2,304 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,483 · 2022: $725 · 2024: $2,039 · 2025: $2,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,343.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,342.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $1,025.91 | 2021-2025 | Xyosted |
| Amneal Pharmaceuticals LLC | $591.25 | 2021-2025 | Unithroid |
| Amgen INC. | $580.96 | 2021-2025 | Evenity, Tepezza, Prolia |
| Novo Nordisk INC | $504.62 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $471.47 | 2021-2022 | |
| Lilly USA, LLC | $471.22 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Mannkind Corporation | $318.81 | 2021-2024 | |
| Cequr Corporation | $283.84 | 2024-2025 | Cequr Simplicity |
| Amphastar Pharmaceuticals, INC. | $193.56 | 2024-2025 | Baqsimi |
| Radius Health, INC. | $178.46 | 2024-2025 | Tymlos |
| Sanofi-Aventis U.S. LLC | $169.01 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.02 | 2021-2025 | Jardiance |
| Dexcom, INC. | $133.11 | 2021-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $129.87 | 2022-2025 | |
| Abbvie INC. | $114.33 | 2024-2025 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $102.33 | 2024-2025 | Minimed 780g |
| Alexion Pharmaceuticals, INC. | $95.94 | 2024-2025 | Strensiq |
| Ascendis Pharma Endocrinology INC | $82.51 | 2024-2025 | Yorvipath |
| Beta Bionics, INC. | $75.11 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Kyowa Kirin, INC. | $71.08 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $65.99 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $58.46 | 2024-2025 | Gvoke Hypopen |
| Ibsa Pharma INC. | $49.90 | 2024-2025 | Licart, Tirosint, Flector |
| Merck Sharp & Dohme LLC | $49.23 | 2021 | |
| Recordati_rare_diseases_inc. | $47.00 | 2024 | Signifor Lar, Isturisa |
| Corcept Therapeutics | $44.46 | 2025 | Korlym |
| Janssen Pharmaceuticals, INC | $41.61 | 2021 | |
| Novartis Pharmaceuticals Corporation | $41.08 | 2024-2025 | |
| Pfizer INC. | $34.91 | 2024-2025 | |
| Zealand Pharma US, INC. | $33.68 | 2021 | |
| Neurocrine Biosciences, INC. | $33.16 | 2025 | |
| Vistapharm, INC. | $32.32 | 2021 | |
| Tandem Diabetes Care, INC. | $32.14 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Alvogen INC | $30.74 | 2024 | Teriparatide |
| Boston Scientific Corporation | $29.65 | 2024 | Wavewriter Alpha Prime 16 |
| Rhythm Pharmaceuticals, INC. | $25.74 | 2022 | |
| Horizon Therapeutics Plc | $25.53 | 2021 | |
| Sequel Med Tech, LLC | $24.89 | 2025 | Twiist |
| Amarin Pharma, INC. | $23.80 | 2021 | |
| Lifescan, INC. | $22.47 | 2021 | |
| Esperion Therapeutics, INC. | $20.15 | 2025 | Nexletol |
| Nestle Healthcare Nutrition INC. | $19.29 | 2021 | |
| Ascensia Diabetes Care US INC. | $17.14 | 2024 | |
| Insulet Corporation | $15.13 | 2025 | Omnipod |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.